Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NHLBI

HIGH RELAXIVITY MULITIVALENT GADOLINIUM ON A PEPTIDE SCAFFOLD

  • Read more about HIGH RELAXIVITY MULITIVALENT GADOLINIUM ON A PEPTIDE SCAFFOLD
US Application 62/873,272
Filed on 2019-07-12

A Pre-emphasis Technique Based On The Temperature-dependent Gradient System Behavior For Trajectory Correction In MR Imaging

  • Read more about A Pre-emphasis Technique Based On The Temperature-dependent Gradient System Behavior For Trajectory Correction In MR Imaging
US Application 62/835,882
Filed on 2019-04-18

ApoE-ApoCII Chimeric Peptides

  • Read more about ApoE-ApoCII Chimeric Peptides
US Application 62/700,751
Filed on 2018-07-19

METHODS FOR ASSESSING CARDIOVASCULAR DISEASE OR INFLAMMATORY DISEASE RISK USING NON-EXCHANGEABLE LIPID PROBE

  • Read more about METHODS FOR ASSESSING CARDIOVASCULAR DISEASE OR INFLAMMATORY DISEASE RISK USING NON-EXCHANGEABLE LIPID PROBE
US Application 62/844,957
Filed on 2019-05-08

MEASUREMENT OF NON-EXCHANGEABLE FLUORESCENT PHOSPHATIDYLETHANOLAMINE TRANSFER FROM DONOR PARTICLES TO PLASMA HDL TO ASSESS CARDIOVASCULAR DISEASE RISK

  • Read more about MEASUREMENT OF NON-EXCHANGEABLE FLUORESCENT PHOSPHATIDYLETHANOLAMINE TRANSFER FROM DONOR PARTICLES TO PLASMA HDL TO ASSESS CARDIOVASCULAR DISEASE RISK
US Application 62/815,604
Filed on 2019-03-08

HELICAL GUIDEWIRES AND RELATED SYSTEMS

  • Read more about HELICAL GUIDEWIRES AND RELATED SYSTEMS
US Application 62/651,692
Filed on 2018-04-02

Improved Image Contrast In Inversion MfR Imaging, Improved Workflow And Inter-scan Reliabilibity In MRI Myocardial Viability Imaging

  • Read more about Improved Image Contrast In Inversion MfR Imaging, Improved Workflow And Inter-scan Reliabilibity In MRI Myocardial Viability Imaging
US Application 61/812,746
Filed on 2013-04-17

Immunogens, Compositions, And Methods For Treating Dyslipidemia

  • Read more about Immunogens, Compositions, And Methods For Treating Dyslipidemia
US Application 62/639,274
Filed on 2018-03-06

ANTIBODIES TARGETING CELL SURFACE DEPOSITED COMPLEMENT PROTEIN C3d AND USE THEREOF

  • Read more about ANTIBODIES TARGETING CELL SURFACE DEPOSITED COMPLEMENT PROTEIN C3d AND USE THEREOF
US Application 62/945,569
Filed on 2019-12-09

Fluorogen-binding RNA Aptamers

  • Read more about Fluorogen-binding RNA Aptamers
US Application 62/489,346
Filed on 2017-04-24

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 27
  • Page 28
  • Page 29
  • Page 30
  • Page 31
  • Page 32
  • Page 33
  • Page 34
  • Page 35
  • …
  • Next page ››
  • Last page Last »
Subscribe to NHLBI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health